Your browser doesn't support javascript.
loading
Simultaneous regression of non-small cell lung cancer and orbital extranodal marginal zone lymphoma with chemoradiotherapy for lung cancer.
Oi, Issei; Saito, Zentaro; Ito, Takanori; Imakita, Takuma; Kanai, Osamu; Fujita, Kohei; Tachibana, Hiromasa; Mori, Minako; Morioshi, Koki; Mio, Tadashi.
Affiliation
  • Oi I; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Saito Z; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Ito T; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Imakita T; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Kanai O; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Fujita K; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Tachibana H; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Mori M; Department of Hematology National Hospital Organisation Kyoto Medical Center Kyoto Japan.
  • Morioshi K; Department of Pathology National Hospital Organisation Kyoto Medical Center Kyoto Japan.
  • Mio T; Division of Respiratory Medicine Center for Respiratory Diseases, National Hospital Organization Kyoto Medical Center Kyoto Japan.
Respirol Case Rep ; 11(7): e01171, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37266456
ABSTRACT
This report describes the case of a 79-year-old Japanese man diagnosed with orbital extranodal marginal zone lymphoma (EMZL) and stage IIIA lung cancer. The patient received concurrent chemoradiation for lung cancer with carboplatin/paclitaxel treatment, resulting in regression of both the lymphoma and lung cancer. To our knowledge, this is the first reported case of concurrent orbital EMZL and lung cancer. In this case, a treatment strategy that prioritized lung cancer treatment was deemed appropriate. This case suggests that chemotherapy with carboplatin and paclitaxel may serve as an effective treatment for both lung cancer and lymphoma.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Respirol Case Rep Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Respirol Case Rep Year: 2023 Document type: Article